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Many potential applications of stem cells require large quantities of cells, especially those involving
large organs such as the liver. For such applications, a scalable reactor system is desirable to ensure a
reliable supply of sufﬁcient quantities of differentiation competent or differentiated cells. We employed





(rMAPC) as well as for directed differentiation of these cells to hepatocyte-like cells. During the 4-day
expansion culture, cell concentration increasedby85-foldwhile expression level of pluripotencymarkers
weremaintained, as well as theMAPC differentiation potential. Directed differentiation into hepatocyte-
like cells on themicrocarriers themselves gave comparable results as observedwith cells cultured in static
cultures. The cells expressed several mature hepatocyte-lineage genes and asialoglycoprotein receptor-1















51of large-scale expansion a
. Introduction
Advances in stem cell science have opened the possibility that
tem cells may be used as therapeutics. Among many organs and
issues for which developing stem cell applications is being pur-
ued, the liver is of particular importance because of the lack of
ffective therapies for liver failure. Existing treatments for liver
ailure are limited, and the only real cure is liver cell or organ trans-
lantation. However, the shortage of donor cells and organs makes
his option often unavailable for a large number of patients. Hep-
tocytes isolated from liver have limited proliferation potential in
ulture, andculturedhepatocytesoftenveryquickly lose their func-
ional attributes. Therefore, there has been intensive research for
source of cells that can proliferate extensively and sustain liverPlease cite this article in press as: Park, Y., et al., Expansion and hepatic dif
suspension culture. J. Biotechnol. (2010), doi:10.1016/j.jbiotec.2010.08.001
unctions in culture. Cultivation of hepatic progenitor cells, immor-
alization of hepatocytes, and derivation of functional hepatocytes
rom stem cells are among the more prevalent approaches (Allain
t al., 2002; Cai et al., 2000, 2007; Herrera et al., 2006; Rogler, 1997;
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Wege et al., 2003; Agarwal et al., 2008; Hay et al., 2008). With the
progress in stem cell science, hepatic cells derived frompluripotent
stem cells, which are capable of virtually unlimited self-renewal,
have great potential to be such a steady cell source.
The liver is the largest organ in the adult body. Any therapeu-
tic application will require a large quantity of cells in the order of
∼109–1010 cells per treatment. Employing a scalable reactor sys-
tem can enable a sufﬁcient supply of differentiation competent or
differentiated cells to meet such a clinical need. Since the conven-
tional method of expanding and differentiating stem cells in tissue
culture plates is labor intensive and difﬁcult to scale up, differ-
ent culture systems for expansion and differentiation of stem cells
have been investigated; rotary culture systems, perfusion culture
systems, and stirred suspension systems have been employed for
various stem cell cultures (Cameron et al., 2006; Fok and Zanstra,
2005; Gilbertson et al., 2006; Li et al., 2006; Liu et al., 2006; Zhao et
al., 2005; Bauwens et al., 2005; Schroeder et al., 2005). Among those
systems, stirred suspension culture has the advantage of having
been widely used in growing mammalian cells for decades. It also
allows high-density culture in a more homogeneous environment,
and should allow one to monitor and control culture parameters.ferentiation of rat multipotent adult progenitor cells in microcarrier
Stirred reactor cultures have been used to expand or differentiate 59
hematopoietic stem and progenitor cells (HSPCs), neural stem cells 60
(NSCs), and human and mouse embryonic stem cells (ESCs) grown 61
as embryoid bodies (EBs) (Cameron et al., 2006; Fok and Zanstra, 62






















































































































Y. Park et al. / Journal of Bi
onolayers like those on tissue culture plates, microcarriers have
he advantage of providing a large surface area for a given reactor
olume.
Microcarriers are particles, typically made of cellulose, glass,
lastic, or polyester, and usually with diameters of 100–250m.
y providing a surface for attachment, they allow anchorage-
ependent cells to be cultivated in stirred tank bioreactors for
arge-scale operations. They have been used for cultivation of
ouse and human ESCs, mesenchymal stem cells, and umbilical
ord stem cells (Fernandes et al., 2007; Chiu et al., 2005; Kehoe
t al., 2010; Lock and Tzanakakis, 2009; Nie et al., 2009; Oh et
l., 2009; Frauenschuh et al., 2007; Yang et al., 2007). For dif-
erentiation applications, microcarriers have been used in a few
tudies wherein pluripotent stem cells were differentiated into
ardiomyocyte-like cells, endoderm progenitor cells, and early tri-
ineage cells (Cameron et al., 2006; Fok and Zanstra, 2005; Bauwens
t al., 2005; Lock and Tzanakakis, 2009).
In this study, using rat multipotent adult progenitor cells
rMAPCs) as a model system, we show that microcarrier culture
as the potential of being a highly efﬁcient scalable means of stem
ell expansion and directed hepatocyte differentiation.
. Materials and methods
.1. Establishment and maintenance of rat MAPC line
One rat MAPC line (rMAPC-1) was used in this study. The iso-
ation of rat MAPC lines has been previously described (Breyer et
l., 2006; Ulloa-Montoya et al., 2007). To explain the procedure in
hort, rMAPC-1 were isolated from bone marrow of the tibia and
emur of a 4-week-old female rat (Fischer). Isolated bone marrow
ellswereplatedon6-well tissue cultureplates inMAPCmediumat
×106 cells/well and cultured in a 5%O2 and5–6%CO2 incubator at
7 ◦C. After 4 weeks of culture, hematopoeitic cells were removed
sing magnetic microbeads against CD45 and Ter119 (Miltenyi
iotec) and the remaining cells are seeded into 96-well plates at
–10 cells/well. Small and spindle shaped cells that appeared in
he wells were subsequently expanded and screened for MAPC
henotype (expression of Oct4, Rex1 and CD31) and tri-lineage
neuroectoderm, endoderm, mesoderm) differentiation potential
Breyer et al., 2006). The established MAPC cell line was main-
ained at 37 ◦C in 5% oxygen and 5–6% CO2 at a seeding cell density
f 300 cells/cm2 and passaged using 0.05% (w/v) Trypsin–EDTA
5mg/l, Cellgro) every 2 days (Breyer et al., 2006).
.2. MAPC medium
Basal culture medium consisted of a 60/40 (v/v) mixture of
ow glucose Dulbecco’s Modiﬁed Eagle media (DMEM) (Gibco,
SA) and MCDB-201 (Sigma) supplemented with 0.026g/ml
scorbic acid 3-phosphate (Sigma), linoleic acid bovine serum
lbumin (LA–BSA, Sigma) (ﬁnal concentrations of 103g/ml BSA
nd 8.13g/ml linoleic acid), insulin–transferrin–selenium (ITS,
igma) (ﬁnal concentration 10g/ml insulin, 5.5g/ml trans-
errin, 0.005g/ml sodium selenite), 0.02g/ml dexamethasone
Sigma), 4.3g/ml -mercaptoethanol. For MAPC expansion, basal
edium was supplemented with 2% (v/v) qualiﬁed fetal bovine
erum (Hyclone). In addition, MAPC medium also contained
hree protein factors: human platelet derived growth factorPlease cite this article in press as: Park, Y., et al., Expansion and hepatic di
suspension culture. J. Biotechnol. (2010), doi:10.1016/j.jbiotec.2010.08.001
PDGF-BB, R&D) (10ng/ml), mouse epidermal growth factor (EGF,
igma) (10ng/ml), and mouse leukemia inhibitory factor (LIF)
Chemicon, ESGRO) (103 units/ml). All media used were also sup-
lemented with 100 IU/ml penicillin and 100g/ml streptomycin
Gibco). PRESS
ology xxx (2010) xxx–xxx
2.3. Suspension ﬂask culture of MAPC on microcarriers
Cytodex 1, a crosslinked dextran microbead with N,N-
diethylamioethyl groups on the surface, is microporous, with a
void fraction greatly exceeding 90%, and support cell growth on
their external surface. Cytodex 1 was purchased from GE Health-
care as dry powders, and the stock was prepared by washing 1g of
microcarrier powder with PBS for 3–5 times. Swollen beads were
sedimented in 100ml fresh PBS and sterilized by autoclaving.
Prior to suspension culture, microcarriers were washed with
low glucose DMEM (Gibco) twice and incubated in MAPC medium
for 2h at 37 ◦C. rMAPC cultured on 10 cm tissue culture plates
(NUNC) were washed with PBS. 1ml 0.05% (w/v) Trypsin–EDTA
(Cellgro)was added to eachplate and theplateswere lightly tapped
several times. 5ml of previously collected culture supernatant was
added to each well to neutralize trypsin. The cells were collected,
washed, and resuspended inMAPC expansionmediumat a concen-
tration of 1.2×106 cells/ml. Cells were added to 12mg/ml Cytodex
1 microcarriers at the concentration of 0.6×106 cells/ml in 2ml
culture medium. The mixture was incubated for 30min at 37 ◦C to
allow initial cell attachment to the beads with occasional shaking
of the tube. Then themixture was transferred into a 98ml of MAPC
expansion medium in a 250ml spinner ﬂask (Wilbur). The culture
was stirred at 70 rpm on a belt-driven magnetic stir plate (Bellco),
and maintained at 37 ◦C, 5% O2 tension and 5% CO2 for 4 days of
expansion culture without any medium change.
2.4. In vitro directed hepatic differentiation
MAPCwere differentiated into hepatocytes by using a four-step
20 days hepatic differentiation protocol with modiﬁcations. For
static plate differentiation, cells were inoculated in an ultra-low
attachment 24-well plate (Corning) at a starting cell concentra-
tion of 1.2×104 cells/ml with 0.23mg/ml Cytodex 1 microcarriers.
For stirred suspension differentiation, cells were inoculated in a
250ml spinner ﬂask at 3.6×104 cells/mlwith 0.6mg/ml of Cytodex
1 microcarriers in 100ml MAPC medium. The cells were expanded
in an incubatorwith5%O2, 5%CO2, at 37C.After 2daysof expansion
culture, when the cells are 80–90% conﬂuent on the microcar-
rier surface, the cells with microcarriers were washed once with
PBS and resuspended in 1ml of hepatic differentiation medium
for static plate differentiation or 80ml of hepatic differentiation
medium in a 250ml spinner ﬂask for stirred suspension differentia-
tion. Thecompositionofdifferentiationbasalmediumwas thesame
as basal MAPC medium except that ITS and LA–BSA were at 25% of
the amount in MAPC medium, and the concentration of dexam-
ethasone was at 0.4g/ml and the three protein factors and serum
were absent. Furthermore, additional protein factors were added
as described below. The cytokines and growth factor supplements
were added as follows: (i) day 0: Activin A (100ng/ml) and Wnt3a
(50ng/ml); (ii) day 6: bFGF (10ng/ml) and BMP4 (50ng/ml); (iii)
day 10: FGF8b (25ng/ml), aFGF (50ng/ml) and FGF4 (10ng/ml);
(iv) day 14: HGF (20ng/ml) and Follistatin (100ng/ml). Differen-
tiations were carried out at 21% O2 and 5% CO2 37C for 20 days
with 50%media change, corresponding to the differentiation stage,
every 2 days.
2.5. RNA isolation and quantitative real time polymerase chain
reaction (qRT-PCR)
Total RNA was isolated from rMAPC cell lysates using RNAeasyfferentiation of rat multipotent adult progenitor cells in microcarrier
microkit (Qiagen) according to instructions provided in the kit. 179
cDNA was synthesized from the extracted RNA using the Super- 180
script III reverse transcriptase (Invitrogen) method. The PCR mix 181
consisted of cDNA samples, SYBR Green Mix PCR reaction buffer 182
(Applied Biosystems) and primers (5M stocks, sequence in 183
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Table 1
List of primer sequences.
Tissue/lineage Gene Forward primer Reverse primer
Housekeeping Gapdh AAGGGCTCATGACCACAGTC GGATGCAGGCATGATGTTCT




















































































247Differentiation markers Sox2 GGCCAAC
Pax6 GTCCATCT
Flk1 CCAAGCT
able 1). The qRT-PCR reaction was run on a Realplex mastercycler
Eppendorf) using the following program: 50 ◦C for 2min, 95 ◦C for
0min, and 40 cycles at 95 ◦C for 15 s and 60 ◦C for 1min followed
y a dissociation protocol to obtain a melting curve. Transcription
bundance relative to GAPDH was calculated as Ct which is Ct
transcript of interest)−Ct (GAPDH) and transcript abundance in
ample relative to day 0 was calculated as Ct (day 0)− Ct (day
f sample).
.6. Intracellular staining for Oct4 by ﬂow cytometry
Trypsinized cells were washed with and suspended in PBS with
% (v/v) serum. After 15–20min ﬁxing with 4% paraformalde-
yde (PFA), and 1h blocking in SAP buffer (PBS with 0.1% (w/v)
aponin and 0.05% (w/v) sodium azide) supplemented with 10%
onkey serum, cells were incubated for 1h with 1g/ml Oct3/4
ntibody (Santa-Cruz, N19) or Goat IgG isotype control (Jackson
mmunoresearch)diluted inSAPbuffer followedby incubatingwith
y5 labeled anti-goat IgG (Jackson Immunoresearch, 1:500 in SAP
uffer) for 30min. Finally, cells were washed and resuspended in
00l PBS for ﬂowcytometry analysis using a FACS Calibur (Becton
ickinson).
.7. Asialoglycoprotein receptor-1 (ASGPR-1) immunostaining by
ow cytometry
To determine functional maturation, ﬂow cytometric anal-
sis was performed with an anti-asialoglycoprotein receptor-1
ASGPR-1) antibody. Cells were harvested from the microcarriers
y trypsinization. After ﬁxing with 4% PFA for 20min and blocking
or 1h in PBS with 3% (v/v) FBS, cells were incubated with anti-
SGPR-1 antibody (Thermoscientiﬁc, 1:10) for 30min, followed
y Alexa 488-conjugated goat anti-mouse IgG secondary antibody
Invitrogen, 1:500) for 30min. Then cells were washed and resus-
ended in 500l PBS for ﬂow cytometry analysis using a FACS
alibur (Becton Dickinson).Please cite this article in press as: Park, Y., et al., Expansion and hepatic dif
suspension culture. J. Biotechnol. (2010), doi:10.1016/j.jbiotec.2010.08.001
.8. Phosphoinopyruvate carboxykinase (PEPCK)
mmunostaining
Cell-laden-microcarriers were ﬁxed with 4% PFA for 20min and
locked in SAP serum buffer for 1h. Cells were stained with anTGGATTCTA GTTTACTGGCACCACGTCCT
TTGGGAAA TAGCCAGGTTGCGAAGAACT
CACAAAAA CCAACCACTCTGGGAACTGT
anti-PEPCK antibody in SAP buffer (Santa-cruz, 1:2000) at 4 ◦C for
overnight and stainedwithA488 anti-rabbit IgG (Invitrogen, 1:500)
for 30min. Then cells–microcarriers were washed, resuspended in
PBS, andobservedunder invertedﬂuorescentmicroscope (Axiovert
200, Zeiss).
2.9. Cell viability staining
The “live/dead viability/cytotoxicity kit” (Invitrogen) was used
to stain cells on microcarriers with calcein and ethidium. Compo-
nent Bwas added ﬁrst to DPBS (1:1000) and then component Awas
added to DPBS with component B (1:2000). Cells were incubated
with the staining solution for15–30minat37 ◦C. Cellswerewashed
oncewith PBS andobservedunder invertedﬂuorescentmicroscope
(Axiovert 200, Zeiss). Live and dead cells appear as green and red,
respectively.
2.10. Cell enumeration by nuclei counting
Microcarriers from 1ml culture were centrifuged at 500 rpm
for 30 s to remove supernatant. After adding 300–500l count-
ing staining solution (0.1% (w/v) crystal violet (Sigma) in 0.1M
citric acid solution (Sigma)), the sample was incubated for 1h
at 37 ◦C. Nuclei were released by gentle shearing using a Pas-
teur pipette in a vertical position. The nuclei were counted with a
hemacytometer.
For ﬁxative staining, cells on microcarriers in 1ml culture were
stained by adding a drop or two of ﬁxative staining solution (0.5%
(w/v) crystal violet in40%ethanol and60%PBS) for 1–2min. Stained
cells–microcarriers were washed with PBS twice to remove the
staining solution from the supernatant.
2.11. Albumin and urea secretion assayferentiation of rat multipotent adult progenitor cells in microcarrier
The albumin secretion ratewas quantiﬁed using the rat albumin 248
ELISAquantitationkit (Bethyl) according to instructionsprovided in 249
the kit. Urea production rate was measured by using QuantiChrom 250
urea assay kit (BioAssay Systems) following the instructions pro- 251
vided in the kit for low urea samples. 252
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311ig. 1. Cultivation of rMAPC on microcarriers: (A) crystal violet staining of cells on m
live) and red (dead)); (C) growth kinetics of rMAPC expanded in microcarrier spin
eader is referred to the web version of the article.)
. Results
.1. MAPC expansion on microcarriers
MAPCswere inoculated ontomicrocarriers at a seeding concen-
ration of 6×105 cells/ml in 2ml culture medium and incubated
t 37 ◦C for not more than 30min with occasional shaking in
rder to increase the frequency of direct contact between micro-
arriers and cells. Immediately after inoculation, MAPCs attached
o the bead surface readily. With the seeding density we used,
here were approximately 3–8 cells attached to each bead after
0min incubation. Those cell-ladenmicrocarriers were then trans-
erred into a 250ml spinner ﬂask with a 100ml working volume of
edium. During 4 days of suspension culture, MAPCs proliferated
orming multiple layers of cells on most microcarriers (Fig. 1). Cal-
ein–ethidiumstain of cells onmicrocarriers (day 4) show that cells
etained high viability for 4 days (Fig. 1B). The cell concentration
ncreased from1.2×104 to 1.0×106 cells/ml after 4 days of culture
quivalent to more than 80-fold of cell expansion (Fig. 1C). There
eemed to be an initial lag of population doubling time (about 21h)
uring day 0–1, but this may be overestimated partially because
ot all cells from the initial cell concentration attach to microcarri-
rs. The population doubling time was about 12h during day 1–3,
omparable to that seen whenMAPCs were cultivated on a regular
issue culture plates (12–14h). After day 3, MAPC began to form
ulti-layers, and the doubling time increased to more than 24h.
.2. Maintenance of undifferentiated MAPC on microcarriers in
tirred suspension culturePlease cite this article in press as: Park, Y., et al., Expansion and hepatic di
suspension culture. J. Biotechnol. (2010), doi:10.1016/j.jbiotec.2010.08.001
We evaluated the retention of potency-related markers on
APCs expanded on microcarriers for 4 days. The expression lev-
ls of key MAPC transcripts, Octamer-binding transcription factor
(Oct4), Sal like 4 (Sall4), RNA exonulease 1 (Rex1) and CD31, and
arlydifferentiation transcripts,SRY (sexdetermining regionY)-box2arriers (day 4); (B) viability staining of cells on microcarrier (day 4) (merged green
lture (n=3). (For interpretation of the references to color in this ﬁgure legend, the
(Sox2), Paired box 6 (Pax6), Alpha-fetoprotein (Afp), Flt-related recep-
tor tyrosine kinease (Flk1) were assessed by qRT-PCR on day 0, day
2, and day 4. Transcripts of Oct4, Sall4, and Rex1 were sustained at
high levels during MAPC proliferation in stirred reactor microcar-
rier culture (Fig. 2A). CD31 expression was also maintained during
that period (Fig. 2A). Expression of genes which are indicative of
early differentiation of MAPC into three different lineages (Sox2,
Pax6, Afp, and Flk1) were checked. Differentiationwas not detected.
Pax6 and especially Afp, a gene which is rapidly up-regulated when
MAPCs differentiate spontaneously, remained undetected during
4 days of expansion culture (Fig. 2B). Sox2 and Flk1 transcript lev-
els slightly increased on day 4 as the cells form multi-layers on
microcarriers (Fig. 2B).
Expression of Oct4 protein, a critical pluripotency-related
marker for MAPC, was also analyzed by intracellular Oct4 protein
staining and quantiﬁed by ﬂow cytometry. Cells were detached
from themicrocarriers after the expansion culture and stainedwith
an anti-Oct3/4 antibody. Oct4 protein levels were maintained dur-
ing the microcarrier culture. Approximately 70% of the cells were
Oct4+ after 4 days (Fig. 2C). The percentage of Oct4+ cells from
microcarrier culture was comparable to the percentage of Oct4+
cells (75%) from conventional static culture on tissue culture plates
(Fig. 2C). Our ﬁndings demonstrate that MAPC in microcarrier sus-
pension culture without any medium change can be expanded
>80-fold while maintaining stable pluripotency gene expression.
3.3. Hepatocyte differentiation of MAPC on microcarriers
3.3.1. Differentiation in static culture
The feasibility of employing microcarrier in hepatic differenti-fferentiation of rat multipotent adult progenitor cells in microcarrier
ation was ﬁrst investigated in static culture. Cells were expanded 312
on microcarriers for 2 days to reach conﬂuent monolayer of cells. 313
MAPC culture medium was then replaced with differentiation 314
medium containing cytokines as described in Section 2. The cell 315
concentration slightly increased initially and then decreased until 316
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388ig. 2. rMAPC were maintained undifferentiated in microcarrier: (A) transcript lev
arly differentiation markers Sox2 (), Afp (), Flk1 (), Pax6 () (n=3); (C) intracel
ay 10. As the differentiation proceeded, cell morphology changes
ere similar to those seen in hepatic differentiation in 2D on
issue culture plates. As the cells proliferated on microcarriers,
ome started to form bulges, and the bulge size increased towards
he end of the differentiation (Fig. 3A). Immunostaining for phos-
hoinopyruvate carboxykinase (PEPCK), for a gene involved in
luconeogenesis that becomes expressed near birth during devel-
pment, identiﬁed small regions of positive cells (Fig. 3B). The
evel of liver-speciﬁc transcripts was evaluated at the end of hep-
tic differentiation in 2D and in 3D on microcarriers. Hepatic
ranscripts of alpha-fetoprotein (Afp), transthyretin (Ttr), Albumin,
lpha-1-antotrypsin (Aat), tyrosine aminotransferase (Tat), glucose-
-phosphate (G6p), microsomal glutathione S-transferase1 (Mgst1),
actor V, Arginase1, and hepatocyte nuclear factor 4 alpha (Hnf4˛)
ere expressed at signiﬁcant levels at the end of differentia-
ion (day 20). The averaged expression level of hepatic markers
bserved from three replicate runs was comparable to that seen in
ifferentiation carried out in 2D on culture plates (Fig. 3C). By FACS,
8% of the cells expressed asialoglycoprotein receptor (ASGPR-1),
hich is a type II transmembrane glycoprotein expressed on hepa-
ocytes (Fig. 3D).Albuminsecretion ratewas0.06±0.03pg/cell/day
Table 2). Urea was produced at 17.9±5.8pg/cell/day (Table 2).
hus,MAPConmicrocarriers can be differentiated into hepatocyte-
ike cells as shown by the up-regulation of hepatic-genes and the
ecretion of albumin and urea.
.3.2. Differentiation in stirred suspension culture
Next, MAPC were expanded in microcarrier culture in a spin-
er ﬂask and directed differentiation to hepatic lineagewas carried
ut subsequently. MAPC were inoculated at 3.1×104 cells/ml with
.6mg/ml of Cytodex 1 microcarriers. Upon reaching 80–90%
onﬂuent and a cell concentration of 3.0×105 cells/ml, MAPC-
aden-microcarriers were washed with PBS once and resuspended
n differentiation medium as prescribed by differentiation proto-
ol. The cell concentration increased to 6.7×105 cells/ml after dayPlease cite this article in press as: Park, Y., et al., Expansion and hepatic dif
suspension culture. J. Biotechnol. (2010), doi:10.1016/j.jbiotec.2010.08.001
and thendecreased to 4.2×105 cells/ml after treatment inActivin
and Wnt3a for 6 days. The concentration again increased up to
.8×105 cells/ml on day 10, then decreased again towards the end.
orphological changes of the cells seen in the bioreactorwere sim-
lar to those seen in static culture. Bulges of cells on microcarriersluripotency markers Oct4 (), Sall4 (), CD31 (), Rex1 (); (B) transcript levels of
ct4 protein expression by ﬂow cytometry.
were also seen and their size increased (Fig. 4). After 20 days of
hepatic differentiation, cells retained high viability.
We also monitored gene expression involved during hepatic
differentiation in the spinner ﬂask culture. Transcript levels of
the deﬁnitive endoderm genes, Goosecoid (Gsc), Chemokine (C-X-C
motif) receptor 4 (Cxcr4), Mix1 homeobox-like 1 (Mixl1), and Eome-
sodermin homolog (Eomes) peaked on day 6 indicating the MAPCs
were committed to deﬁnitive endoderm stage as expected in hep-
atic differentiation (Fig. 5). Transcripts for hepatic endodermgenes,
Afp and Ttr, increased from day 6 onwards and were maintained at
a high level throughout the differentiation process. Transcripts for
the more mature hepatic-genes Albumin, Aat, Tat, G6p, Mgst1, Fac-
tor V, Arginase1, and Hnf4˛ increased signiﬁcantly by day 20 of the
hepatic differentiation. The expression level of mature transcripts
was comparable to that in static differentiation. In addition, dif-
ferentiated cells at day 20 secreted albumin at 1.03pg/cell/day, or
about 12% of the level secreted by adult rat hepatocytes, and urea
was secreted at 17.4pg/cell/day (Table 2). These results suggest
that hepatic differentiation on microcarriers in stirred suspension
culture can provide hepatic cells in a larger scale.
4. Discussion
Muchprogresshasbeenmade indirectedhepaticdifferentiation
of various stem cells, including human andmouse embryonic stem
cells (ESCs) and inducedpluripotent stemcells (iPS cells) in the past
few years (Sancho-Bru et al., 2009; Si-Tayeb et al., 2010; Song et al.,
2009). The achievements have renewed the hope that cell trans-
plantation or bioartiﬁcial liver devices involving stem cell-derived
hepatocytes may be getting closer to reality. The recent demon-
stration of iPS cell differentiation to hepatocyte-like cells also raises
the prospect that iPS cells derived frompatients of different genetic
backgroundcanbedifferentiated intohepatocytes andused for tox-
icity andmetabolic studies. These advances heighten hopes as well
as highlight the need for the development of robust bioprocesses,ferentiation of rat multipotent adult progenitor cells in microcarrier
which are capable of producing large numbers of stem cells or their 389
hepatic progenies appropriate for various applications. 390
The feasibility of cultivating different stem cells has been 391
demonstrated for various types of bioreactors such as perfusion 392
reactors, rotating vessels, spinner reactors, and others (Cameron 393
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413ig. 3. Hepatic differentiation in staticmicrocarrier culture (n=3): (A)morphology o
xpression by ﬂow cytometry on cells differentiated on (i) tissue culture plate and o
For interpretation of the references to color in this ﬁgure legend, the reader is refe
t al., 2006; Fok and Zanstra, 2005; Gilbertson et al., 2006; Li et
l., 2006; Liu et al., 2006; Zhao et al., 2005; Bauwens et al., 2005;
chroeder et al., 2005). Ideally, a bioreactor should provide a homo-
eneous environment, for a high concentration of cells, and allow
asy access for sampling. In this regard, a stirred vessel based sys-
em is superior to re-circulating ﬂat-bed and rotating vessels. Some
tem cells are capable of proliferation and/or differentiation when
rownas aggregates, such as EBs fromESCs.Upon formationof suchPlease cite this article in press as: Park, Y., et al., Expansion and hepatic di
suspension culture. J. Biotechnol. (2010), doi:10.1016/j.jbiotec.2010.08.001
ggregates, they can be grown in a stirred bioreactor. However,
ot all cells can be cultivated as aggregates. Microcarrier culture
ombined with suspension culture systems allows the growth of
dherent-dependent stem cells in high density.
able 2
lbumin secretion and urea production rates from hepatic differentiation.
Rate (pg/cell/day) Static culture (n=3) Spinner culture (n=1)
Albumin 0.06 ± 0.03 1.03







42016; (B) PEPCK (green) staining; (C) transcript levels of hepaticmarkers; (D) ASGPR-1
icrocarriers in static culture (blue: cells from differentiation day 20; red: isotype).
the web version of the article.)
Themicrocarrier concentration used in this studywas relatively
low, and the culture was initiated with a relatively low inoculation
cell concentration. Hence, we inoculated cells onto microcarriers
under stationary conditions with a reduced volume to increase the
microcarrier and cell concentrations, thereby increasing the prob-
ability of successful contacts between cells and microcarriers. The
initial cell distribution on microcarriers greatly affects subsequent
growth kinetics. Occasionalmixing resulted in a better distribution
of cells on the microcarriers. We observed that MAPCs attached
relatively fast to microcarriers, comparable to the attachment of
ﬁbroblastic cells (Tao et al., 1987).
Rat MAPCs are typically cultured on ﬁbronectin-coated dishes
at a low initial density of 300 cells/cm2 as it was thought that
maintenance at a high density might result in differentiation and
a corresponding loss of potency, as is observed for MSC culturefferentiation of rat multipotent adult progenitor cells in microcarrier
(Breyer et al., 2006; Jiang et al., 2002; Javazon et al., 2004). Upon 421
inoculating into a Cytodex 1 microcarrier culture, even without 422
ﬁbronectin coating, MAPC readily attach to microcarriers and pro- 423
liferate at a growth rates similar to that seenon tissue culture plates 424
(Fig. 1). EventuallyMAPC formmultiple layersonmicrocarriers and, 425
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(Fig. 4. Morphology of cells during hepatic differentiation: (A
heir doubling time increased from 14 to 24h. This result agrees
ith previous studies involving MAPC aggregate and mESC aggre-
ate cultures; the doubling time of MAPC grown as aggregates is
bout 23h (manuscript submitted), and a similar increase in dou-
ling timewas also notedwhenmESCswere cultured as aggregates
Fok and Zanstra, 2005). It is possible that cells grown as multi-
ayers on microcarriers actually resemble cells in aggregates in
erms of morphology, structure, and physiological characteristics.
The high cell density seen on microcarriers did not affect thePlease cite this article in press as: Park, Y., et al., Expansion and hepatic dif
suspension culture. J. Biotechnol. (2010), doi:10.1016/j.jbiotec.2010.08.001
otency of MAPC over the short reactor culture period. The cells
ontinued toexpress thehigh levelsofOct4-transcripts andprotein,
transcription factor expressed in early embryonic development
ndwhich is in ESCs essential for themaintenance of pluripotency.
e have also shown that the level of Oct4-transcripts and protein
ig. 5. Hepatic differentiation in spinner microcarrier culture (n=1). Transcript levels of
); (B) hepatic endoderm markers Afp (), Ttr (); (C) mature hepatic markers from day; (B) day 14; (C) day 20; (D) vitality staining on day 20 cells.
in MAPC is correlated with the potency of the cells (Ulloa-Montoya
et al., 2007). Other pluripotency-related markers of MAPC, namely
Rex1, Sall4, and CD31, were expressed in MAPC in microcarrier
stirred bioreactor culture at levels comparable to cells maintained
at low density in 2D cultures. We also did not detect increased
expression of genes closely associated with differentiation such as
Sox2, Pax6, Flk1, and Afp (Fig. 2). Slight up-regulation of Sox2 and
Flk1was observed on day 4 of expansion culture.We speculate that
this increased expressionmay be attributed to the high cell densityferentiation of rat multipotent adult progenitor cells in microcarrier
within the multiple cell layers on the microcarrier beads. Similar 449
phenotype, with no apparent loss differentiation potency, has also 450
been observed in ourMAPC aggregates and other systems (Purpura 451
et al., 2008; Rizzino, 2009) (Subramanian et al., submitted). As Pax6 452
transcript levelwas not increased during expansion,with the slight 453








































































































































Y. Park et al. / Journal of Bi
ncrease of only Sox2, an early commitment to the neuroectoderm
ineage is unlikely.
Along with maintenance of MAPC potency during expansion,
e used microcarrier culture systems for hepatocyte differentia-
ion. This culture system allows large-scale hepatic differentiation;
bout 4×107 cells with hepatic phenotype and functions were
btained from 80ml culture. The extent of differentiation into
epatocyte-like cells on microcarriers, as judged by expression of
arious hepatocyte-speciﬁc genes, was similar to that seen in dif-
erentiation in 2D or in 3D in culture dishes (Roelandt et al., 2010).
urthermore, the dynamics of liver-speciﬁc gene expression pro-
les were similar in both microcarrier and dish cultures. Deﬁnitive
ndoderm transcripts (Gsc, Cxcr4, Mixl1, and Eomes) peaked during
he earlier phase (day 6) of the differentiation, followed by expres-
ion of hepatic endoderm genes (Afp, Ttr) from day 6 onwards.
ranscripts for mature hepatic-genes such as Albumin, Aat, Tat,
6p, Mgst1, Factor V, Arginase1, and Hnf4˛ were signiﬁcantly up-
egulated towards the end of hepatic differentiation (Fig. 5). This
ene expression proﬁle conﬁrms that MAPC differentiate accord-
ng to the known hepatic developmental stages, progressing from
oregut endoderm, to fetal liver stemcells (hepatoblasts) andﬁnally
epatocytes. The observation that cell number decreased initially
rom day 0 to day 6 is likely to be associated with the pres-
nce of Activin A in the differentiation medium at this stage, as
bserved in other studies (Fukuchi et al., 2001). The cell number
ubsequently increased from day 10 supporting the notion that
his stage of differentiation corresponds to the hepatoblast stage
f liver development. ASGPR-1, a surface molecule characteristic
f the mature hepatocytes phenotype was used to quantify more
ature hepatocyte-like cells. ASGPR-1 is known to be expressed
n a smaller population of cells (18–22%) than is Albumin in hESC
epatic differentiation (Basma et al., 2009). In MAPC microcarrier
ifferentiation, about 20% of the cells were positive for ASGPR-
, a level similar to conventional two-dimensional differentiation
Fig. 3D). The cells also displayed hepatic functions; albumin and
rea were secreted at the end of differentiation. The differentiated
APC not only expressed albumin transcripts, but also secreted
lbumin at a rate of 1.03pg/cell/day, a level that was higher than
hat from culture dish differentiation (0.06pg/cell/day). Measured
ates for both albumin and urea secretion are still lower than that
f adult rat hepatocytes (Table 2) (Roelandt et al., 2010).
To further improve the microcarrier differentiation system,
dditional technical issues must be addressed. In our multi-step
ifferentiation protocol, the differentiation mediumwith different
ytokines is replaced periodically to drive the differentiation to the
ext stage. As the microcarriers used in this study were microp-
rous, with a void fraction greatly exceeding 90%, a large volume
f residualmedium from the previous differentiation stage is likely
o remain in the interior of cell-laden microcarriers. It is not clear
hether the residual components pose any signiﬁcant effect on the
utcome of differentiation. Because different signaling pathways
re involved in committing cells in the different stages of differen-
iation to thenext stage, it is possible that cytokines remaining from
heprevious stepmayhave antagonistic effects on the ultimate lev-
ls of differentiation. The microcarrier concentration used in this
tudy was low, and therefore the amount of residual components
fter medium replacement was also relatively small. However, in
differentiation bioprocess, with a higher microcarrier concentra-
ion, the effect of these residual cytokines may not be negligible.
sing solid microcarriers that do not have internal pores can min-
mize the potential adverse effects. One can also speculate thatPlease cite this article in press as: Park, Y., et al., Expansion and hepatic di
suspension culture. J. Biotechnol. (2010), doi:10.1016/j.jbiotec.2010.08.001
icroporous microcarriers may act as slow release reservoirs for
otential trophic factors; however, sucha function remains as spec-
lation.
Another aspect of microcarrier application is the recovery of
he cultured or differentiated cell products. Dissociation of cells PRESS
ology xxx (2010) xxx–xxx
frommicrocarrier surface followed by cell-microcarrier separation
is likely to be a necessity in clinical and drug testing applications.
Viable MAPCs can be easily detached frommicrocarriers with high
recovery efﬁciency after a mild trypsin treatment. Differentiated
cells can also be harvested while still retaining their function and
viability. However, enzymatic treatments such as trypsinization
and collagenase treatment on cell detachment can possibly cause
disruption of critical cell surface proteins including ion channels,
growth factor receptors and cell–cell junction proteins (Yang et
al., 2005). This may bring subtle changes in cellular function and
phenotype when cells are repeatedly passaged. For cell-bead dis-
sociation and separation, various methods have been studied from
mesh ﬁlter to employment of temperature-sensitive microcarriers
(Billing et al., 1983;Gaoet al., 2010; Yang et al., 2009). Development
of effectivemethodswill be a crucial advancement allowingmicro-
carriers tobe successfully applied in large-scale stemcell expansion
and directed differentiation processes.
We conclude that microcarrier suspension culture is a robust
method for scale up of MAPC expansion and differentiation to
the hepatic lineage. It will facilitate the transformation of the
laboratory practice of stem cell culture to scalable bioprocesses
generating hepatocyte-like cells at industrial scales for future clin-
ical applications.
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